Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial.

Miles SW, Sheridan J, Russell B, Kydd R, Wheeler A, Walters C, Gamble G, Hardley P, Jensen M, Kuoppasalmi K, Tuomola P, Föhr J, Kuikanmäki O, Vorma H, Salokangas R, Mikkonen A, Kallio M, Kauhanen J, Kiviniemi V, Tiihonen J.

Addiction. 2013 Jul;108(7):1279-86. doi: 10.1111/add.12109. Epub 2013 Mar 1.

PMID:
23297867
2.

Sustained-release methylphenidate in methamphetamine dependence treatment: a double-blind and placebo-controlled trial.

Rezaei F, Emami M, Zahed S, Morabbi MJ, Farahzadi M, Akhondzadeh S.

Daru. 2015 Jan 15;23:2. doi: 10.1186/s40199-015-0092-y.

3.

Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence.

Longo M, Wickes W, Smout M, Harrison S, Cahill S, White JM.

Addiction. 2010 Jan;105(1):146-54. doi: 10.1111/j.1360-0443.2009.02717.x. Epub 2009 Oct 19.

PMID:
19839966
4.

Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder.

Ling W, Chang L, Hillhouse M, Ang A, Striebel J, Jenkins J, Hernandez J, Olaer M, Mooney L, Reed S, Fukaya E, Kogachi S, Alicata D, Holmes N, Esagoff A.

Addiction. 2014 Sep;109(9):1489-500. doi: 10.1111/add.12608. Epub 2014 Jul 8.

5.

Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials.

Kishi T, Matsuda Y, Iwata N, Correll CU.

J Clin Psychiatry. 2013 Dec;74(12):e1169-80. doi: 10.4088/JCP.13r08525.

PMID:
24434105
6.

Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial.

Konstenius M, Jayaram-Lindström N, Guterstam J, Beck O, Philips B, Franck J.

Addiction. 2014 Mar;109(3):440-9. doi: 10.1111/add.12369. Epub 2013 Dec 1.

7.

Mirtazapine to reduce methamphetamine use: a randomized controlled trial.

Colfax GN, Santos GM, Das M, Santos DM, Matheson T, Gasper J, Shoptaw S, Vittinghoff E.

Arch Gen Psychiatry. 2011 Nov;68(11):1168-75. doi: 10.1001/archgenpsychiatry.2011.124.

9.

Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study.

Konstenius M, Jayaram-Lindström N, Beck O, Franck J.

Drug Alcohol Depend. 2010 Apr 1;108(1-2):130-3. doi: 10.1016/j.drugalcdep.2009.11.006. Epub 2009 Dec 16.

PMID:
20015599
10.

Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence.

Heinzerling KG, Swanson AN, Kim S, Cederblom L, Moe A, Ling W, Shoptaw S.

Drug Alcohol Depend. 2010 Jun 1;109(1-3):20-9. doi: 10.1016/j.drugalcdep.2009.11.023. Epub 2010 Jan 25.

11.

A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression.

Patkar AA, Masand PS, Pae CU, Peindl K, Hooper-Wood C, Mannelli P, Ciccone P.

J Clin Psychopharmacol. 2006 Dec;26(6):653-6.

PMID:
17110825
12.

Bupropion for the treatment of methamphetamine dependence.

Elkashef AM, Rawson RA, Anderson AL, Li SH, Holmes T, Smith EV, Chiang N, Kahn R, Vocci F, Ling W, Pearce VJ, McCann M, Campbell J, Gorodetzky C, Haning W, Carlton B, Mawhinney J, Weis D.

Neuropsychopharmacology. 2008 Apr;33(5):1162-70. Epub 2007 Jun 20.

13.

A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence.

Shearer J, Darke S, Rodgers C, Slade T, van Beek I, Lewis J, Brady D, McKetin R, Mattick RP, Wodak A.

Addiction. 2009 Feb;104(2):224-33. doi: 10.1111/j.1360-0443.2008.02437.x.

PMID:
19149817
14.

A randomized, controlled, pilot trial of methylphenidate and cognitive-behavioral group therapy for cocaine dependence in heroin prescription.

Dürsteler-MacFarland KM, Farronato NS, Strasser J, Boss J, Kuntze MF, Petitjean SA, Bürki C, Wiesbeck GA.

J Clin Psychopharmacol. 2013 Feb;33(1):104-8. doi: 10.1097/JCP.0b013e31827bfff4.

PMID:
23277248
15.

Aripiprazole for the treatment of methamphetamine dependence: a randomized, double-blind, placebo-controlled trial.

Coffin PO, Santos GM, Das M, Santos DM, Huffaker S, Matheson T, Gasper J, Vittinghoff E, Colfax GN.

Addiction. 2013 Apr;108(4):751-61. doi: 10.1111/add.12073. Epub 2013 Jan 3.

16.

A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence.

Johnson BA, Ait-Daoud N, Elkashef AM, Smith EV, Kahn R, Vocci F, Li SH, Bloch DA; Methamphetamine Study Group.

Int J Neuropsychopharmacol. 2008 Feb;11(1):1-14. Epub 2007 May 1.

PMID:
17470315
17.

Bupropion for the treatment of methamphetamine dependence in non-daily users: a randomized, double-blind, placebo-controlled trial.

Anderson AL, Li SH, Markova D, Holmes TH, Chiang N, Kahn R, Campbell J, Dickerson DL, Galloway GP, Haning W, Roache JD, Stock C, Elkashef AM.

Drug Alcohol Depend. 2015 May 1;150:170-4. doi: 10.1016/j.drugalcdep.2015.01.036. Epub 2015 Feb 7.

18.

Assessment of pharmacokinetics and pharmacodynamic effects related to abuse potential of a unique oral osmotic-controlled extended-release methylphenidate formulation in humans.

Parasrampuria DA, Schoedel KA, Schuller R, Gu J, Ciccone P, Silber SA, Sellers EM.

J Clin Pharmacol. 2007 Dec;47(12):1476-88. Epub 2007 Oct 25.

PMID:
17962423
19.

Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.

Adler LA, Zimmerman B, Starr HL, Silber S, Palumbo J, Orman C, Spencer T.

J Clin Psychopharmacol. 2009 Jun;29(3):239-47. doi: 10.1097/JCP.0b013e3181a390ce.

PMID:
19440077
20.

Modafinil for the treatment of methamphetamine dependence.

Anderson AL, Li SH, Biswas K, McSherry F, Holmes T, Iturriaga E, Kahn R, Chiang N, Beresford T, Campbell J, Haning W, Mawhinney J, McCann M, Rawson R, Stock C, Weis D, Yu E, Elkashef AM.

Drug Alcohol Depend. 2012 Jan 1;120(1-3):135-41. doi: 10.1016/j.drugalcdep.2011.07.007. Epub 2011 Aug 12.

Items per page

Supplemental Content

Write to the Help Desk